+1 - Roche
+1 - Roche
+1 - Roche
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Pharmaceuticals sales (adjusted)<br />
Q1 '03 growth vs. growth vs. Q1 '02<br />
in CHF m Q1 '02 in CHF in local currencies<br />
<strong>Roche</strong> Prescription1,2 3,136 -7 % 3 %<br />
Genentech Prescription 793 2 % 25 %<br />
Chugai Prescription3 <strong>Roche</strong> world wide<br />
656 205 % 236 %<br />
Prescription group1 4,585 5 % 18 %<br />
OTC 4 406 4 % 13 %<br />
Pharmaceuticals 1 4,991 5 % 18 %<br />
r<br />
1 sales in 2003 and 2002 are adjusted to include the reclassification of CHF 46 million and CHF 54 million of sales<br />
to the Vitamins and Fine Chemicals Division as divisional sales to third parties<br />
2 excludes Nippon <strong>Roche</strong> Rx<br />
3 consists of Nippon <strong>Roche</strong> Rx (Q1 2002) and Chugai Rx (Q1 2003)<br />
4 including Chugai OTC<br />
28
Change language